Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion
被引:17
作者:
Connick, E
论文数: 0引用数: 0
h-index: 0
机构:Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, Denver, CO 80262 USA
Connick, E
Schlichtemeier, RL
论文数: 0引用数: 0
h-index: 0
机构:Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, Denver, CO 80262 USA
Schlichtemeier, RL
Purner, MB
论文数: 0引用数: 0
h-index: 0
机构:Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, Denver, CO 80262 USA
Purner, MB
Schneider, KM
论文数: 0引用数: 0
h-index: 0
机构:Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, Denver, CO 80262 USA
Schneider, KM
Anderson, DM
论文数: 0引用数: 0
h-index: 0
机构:Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, Denver, CO 80262 USA
Anderson, DM
MaWhinney, S
论文数: 0引用数: 0
h-index: 0
机构:Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, Denver, CO 80262 USA
MaWhinney, S
Campbell, TB
论文数: 0引用数: 0
h-index: 0
机构:Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, Denver, CO 80262 USA
Campbell, TB
Kuritzkes, DR
论文数: 0引用数: 0
h-index: 0
机构:Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, Denver, CO 80262 USA
Kuritzkes, DR
Douglas, JM
论文数: 0引用数: 0
h-index: 0
机构:Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, Denver, CO 80262 USA
Douglas, JM
Judson, FN
论文数: 0引用数: 0
h-index: 0
机构:Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, Denver, CO 80262 USA
Judson, FN
Schooley, RT
论文数: 0引用数: 0
h-index: 0
机构:Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, Denver, CO 80262 USA
Schooley, RT
机构:
[1] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80262 USA
[3] Denver Hlth & Hosp Author, Denver Dept Publ Hlth, Denver, CO USA
Human immunodeficiency virus type 1 (HIV-1)-specific memory, or precursor, cytotoxic T lymphocytes (CTL) in 14 subjects who had recently experienced seroconversion were evaluated with respect to virus set point, defined as plasma HIV-1 RNA level 6 months after seroconversion. Env-, Gag-, Pol-, and Nef-specific precursor CTL were detected in Cr-51-release assays, using antigen-stimulated peripheral blood mononuclear cells as effectors and B cell lines infected with HIV-1-vaccinia recombinants as targets. All subjects tested had precursor CTL specific to at least 2 HIV-1 antigens. Detection of Env- specific precursor CTL was associated with a high set point (P = .0221). The number of antigens recognized tended to be greater in subjects with higher set points (rho = .45621; P = .1171). Gag- specific precursor CTL frequency correlated inversely with set point (rho = -.8478; P = .0003). Two heterozygotes for a 32-bp deletion in CCR5 had the lowest set points (P = .0220) and highest Gag precursor CTL frequencies (P = .0128). These data suggest that host factors that restrict viral replication may be important determinants of the level of HIV-1-specific precursor CTL.